Loading...
FibroGen, Inc.
FGEN•NASDAQ
Healthcare
Biotechnology
$7.22
$1.03(16.66%)
FibroGen, Inc. (FGEN) Financial Performance & Statements
Review FibroGen, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-79.95%
↓ 79.95%
Operating Income Growth
46.63%
↑ 46.63%
Net Income Growth
83.26%
↑ 83.26%
Operating Cash Flow Growth
56.19%
↑ 56.19%
Operating Margin
570.33%
↑ 570.33%
Gross Margin
57.78%
↑ 57.78%
Net Profit Margin
42.51%
↑ 42.51%
ROE
4.80%
↑ 4.80%
ROIC
-146.23%
↓ 146.23%
FibroGen, Inc. (FGEN) Financial Statements
Explore quarterly and annual reports for FibroGen, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | -$123.26M | $46.33M | $50.64M | $55.90M |
| Cost of Revenue | -$20.67M | $5.29M | $5.18M | $25.75M |
| Gross Profit | -$102.59M | $41.04M | $45.46M | $30.15M |
| Gross Profit Ratio | $0.83 | $0.89 | $0.90 | $0.54 |
| R&D Expenses | $1.49M | $21.71M | $34.11M | $38.39M |
| SG&A Expenses | -$13.32M | $17.55M | $22.28M | $22.82M |
| Operating Expenses | -$10.93M | $57.82M | $56.38M | $61.21M |
| Total Costs & Expenses | -$31.60M | $63.11M | $61.56M | $86.97M |
| Interest Income | $204000.00 | $3.80M | $0.00 | $2.57M |
| Interest Expense | -$6.53M | $4.99M | $6.06M | $5.00M |
| Depreciation & Amortization | $352000.00 | $739000.00 | $781000.00 | $820000.00 |
| EBITDA | -$91.10M | -$16.78M | -$10.14M | -$27.67M |
| EBITDA Ratio | $0.74 | -$0.36 | -$0.20 | -$0.50 |
| Operating Income | -$91.66M | -$16.78M | -$10.92M | -$31.06M |
| Operating Income Ratio | $0.74 | -$0.36 | -$0.22 | -$0.56 |
| Other Income/Expenses (Net) | $6.73M | -$1.19M | -$6.06M | -$2.43M |
| Income Before Tax | -$84.92M | -$17.97M | -$16.98M | -$33.49M |
| Income Before Tax Ratio | $0.69 | -$0.39 | -$0.34 | -$0.60 |
| Income Tax Expense | -$52000.00 | $12000.00 | -$262000.00 | $33000.00 |
| Net Income | $17.98M | -$17.08M | -$15.54M | -$32.93M |
| Net Income Ratio | -$0.15 | -$0.37 | -$0.31 | -$0.59 |
| EPS | $0.18 | -$0.17 | -$0.16 | -$0.33 |
| Diluted EPS | $0.18 | -$0.17 | -$0.16 | -$0.33 |
| Weighted Avg Shares Outstanding | $100.83M | $100.52M | $99.83M | $98.98M |
| Weighted Avg Shares Outstanding (Diluted) | $100.83M | $100.52M | $99.83M | $98.98M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan